Window Therapeutics

Year 2021
Area Healthcare and Medical

Window Therapeutics is developing cancer therapies designed to work against diseased cells and not healthy ones.

It draws on its proprietary Bottle-brush-Analogue-Macromonomer (BAM) technology to open the therapeutic windows of a wide range of drug classes, offering clinicians and patients more numerous and effective treatment regimens.

A novel prodrug platform as the next generation blood cancer therapy

The company is a spinout from the 2018 project, A novel prodrug platform as the next generation blood cancer therapy.

Targeting cancer with a multidrug nanoparticle

Using bottlebrush particles, researchers can identify and deliver synergistic combinations of cancer drugs